Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 65 out of 100. Health systems and care delivery

Topic: Risk, prevention and care in population studies

Collaborative dementia care programs are effective in addressing the needs of patients with dementia and their caregivers. However, attempts to consider effects on health care spending have been limited, leaving a critical gap in the conversation around value-based dementia care. To determine the effect of participation in collaborative dementia care on total Medicare reimbursement costs compared with usual care. This was a prespecified secondary analysis of the Care Ecosystem trial, a 12-month, single-blind, parallel-group randomized clinical trial conducted from March 2015 to March 2018 at 2 academic medical centers in California and Nebraska. Participants were patients with dementia who were living in the community, aged 45 years or older, and had a primary caregiver and Medicare fee-for-service coverage for the duration of the trial. Telehealth dementia care program that entailed assignment to an unlicensed dementia care guide who provided caregiver support, standardized education, and connection to licensed dementia care specialists. Primary outcome was the sum of all Medicare claim payments during study enrollment, excluding Part D (drugs). Of the 780 patients in the Care Ecosystem trial, 460 (59.0%) were eligible for and included in this analysis. Patients had a median (IQR) age of 78 (72-84) years, and 256 (55.7%) identified as female. Participation in collaborative dementia care reduced the total cost of care by $3290 from 1 to 6 months postenrollment (95% CI, -$6149 to -$431; P = .02) and by $3027 from 7 to 12 months postenrollment (95% CI, -$5899 to -$154; P = .04), corresponding overall to a mean monthly cost reduction of $526 across 12 months. An evaluation of baseline predictors of greater cost reduction identified trends for recent emergency department visit (-$5944; 95% CI, -$10 336 to -$1553; interaction P = .07) and caregiver depression (-$6556; 95% CI, -$11 059 to -$2052; interaction P = .05). In this secondary analysis of a randomized clinical trial among Medicare beneficiaries with dementia, the Care Ecosystem model was associated with lower total cost of care compared with usual care. Collaborative dementia care programs are a cost-effective, high-value model for dementia care. ClinicalTrials.gov Identifier: NCT02213458.

Key findings

Why it matters

In a planned secondary analysis of a randomized trial of 460 Medicare fee-for-service patients with dementia, a telehealth programme was linked to lower total Medicare costs than usual care: a mean of about $526 a month over 12 months, excluding drug costs. In the programme, an unlicensed care guide supported the caregiver and connected the family to dementia specialists. The study measured spending only, not patient or caregiver well-being, and says nothing about treating or preventing Alzheimer's.

Study details

How this study scored 65/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 2 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 1 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record 3 of 4; Institution's track record 2 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. 47 of the 72 points it could be judged on, which is 65 of 100. Total 65 of 100.47 of the 72 points we could judge = 65 of 100

Published in a leading specialty journal. Scored zero for study design because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here and still being cited, so those were left out: it earned 47 of the 72 points we could judge it on, which is 65 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (JAMA internal medicine)
Journal's citation record 3 / 4 JAMA Internal Medicine: journal h-index 258 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2023 — within 6 year(s) of the newest study here
Sample size 2 / 4 780 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 1 / 2 Randomised (as stated in the record)
Times cited — / 7 Citation count not trusted: 6 of 14 library studies citing it were published more than a year before it - a sign OpenAlex merged several works under this DOI — left out of this score
Citations per year — / 5 Citation count not trusted (see above) — left out of this score
Impact for its field and year — / 6 Citation count not trusted (see above) — left out of this score
Cited by studies here — / 6 Library citations not trusted (see above) — left out of this score
Still being cited — / 4 Citation count not trusted (see above) — left out of this score
Senior author's track record 3 / 4 Last-listed author Katherine L. Possin: h-index 57 (OpenAlex, whole career)
Institution's track record 2 / 3 University of California, San Francisco: institution h-index 1,912 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 6 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 37721734)
Free to read 0 / 2 Behind a paywall — scores zero
Points 47 / 72 Scored on 15 of 20 parts. We have no data for the rest, so they are left out: 47 of the 72 points we could judge it on is 65 out of 100.
Total 65 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Guterman Elan, L., Kiekhofer Rachel, E., Wood Andrew, J., Elaine, A. I., Kahn James, G., Sarah, D., et al. (2023). Care Ecosystem Collaborative Model and Health Care Costs in Medicare Beneficiaries With Dementia: A Secondary Analysis of a Randomized Clinical Trial. JAMA internal medicine. https://doi.org/10.1001/jamainternmed.2023.4764

Vancouver

Guterman Elan L, Kiekhofer Rachel E, Wood Andrew J, Elaine AI, Kahn James G, Sarah D, et al. Care Ecosystem Collaborative Model and Health Care Costs in Medicare Beneficiaries With Dementia: A Secondary Analysis of a Randomized Clinical Trial. JAMA internal medicine. 2023. doi:10.1001/jamainternmed.2023.4764. PMID: 37721734.

BibTeX

@article{gutermanelan2023-37721734,
  author  = {Guterman Elan, L. and Kiekhofer Rachel, E. and Wood Andrew, J. and Elaine, Allen I and Kahn James, G. and Sarah, Dulaney and Merrilees Jennifer, J. and Kirby, Lee and others},
  title   = {{Care Ecosystem Collaborative Model and Health Care Costs in Medicare Beneficiaries With Dementia: A Secondary Analysis of a Randomized Clinical Trial}},
  journal = {JAMA internal medicine},
  year    = {2023},
  doi     = {10.1001/jamainternmed.2023.4764},
  pmid    = {37721734},
  url     = {https://doi.org/10.1001/jamainternmed.2023.4764}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

14 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in Health systems and care delivery

Also tagged “care”

996 studies in the library carry the topic tag “care”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 996 tagged studies.

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →